Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives

Mammalian target of rapamycin (mTOR) signaling pathway controls cell energy metabolism. There is an interplay between mTOR and proinflammatory signaling pathways, supporting the role of the pathway in the pathogenesis of inflammatory diseases. Inhibition of mTOR signaling using specific pharmacologi...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cellular physiology Vol. 233; no. 6; pp. 4783 - 4790
Main Authors:	Soltani, Arash, Bahreyni, Amirhossein, Boroumand, Nadia, Roshan, Mostafa karimi, Khazaei, Majid, Ryzhikov, Mikhail, Soleimanpour, Saman, Avan, Amir, Hassanian, Seyed Mahdi
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01.06.2018
Subjects:	Animals Anti-Inflammatory Agents - therapeutic use Arteriosclerosis Arthritis Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - enzymology Arthritis, Rheumatoid - immunology Atherosclerosis Atherosclerosis - drug therapy Atherosclerosis - enzymology Atherosclerosis - immunology Cancer Energy metabolism Humans inflamatory diseases inflammation Inflammation - drug therapy Inflammation - enzymology Inflammation - immunology Inflammation Mediators - antagonists & inhibitors Inflammation Mediators - immunology Inflammation Mediators - metabolism Inflammatory diseases Inhibitor drugs Inhibitors mammalian target of rapamycin Metabolism Molecular Targeted Therapy Neoplasms - drug therapy Neoplasms - enzymology Neoplasms - immunology Neurodegenerative diseases Neurodegenerative Diseases - drug therapy Neurodegenerative Diseases - enzymology Neurodegenerative Diseases - immunology Neurological diseases Pathogenesis pharmacological inhibitors Pharmacology Protein Kinase Inhibitors - therapeutic use Rapamycin Rheumatoid arthritis Sepsis Sepsis - drug therapy Sepsis - enzymology Sepsis - immunology Signal transduction Signal Transduction - drug effects Signaling TOR protein TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - immunology TOR Serine-Threonine Kinases - metabolism inflamatory diseases pharmacological inhibitors mammalian target of rapamycin inflammation
ISSN:	0021-9541, 1097-4652, 1097-4652
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!